📈 Jumpstart Signal Watchlist — September 14, 2026

🏢 What they do: Paysign, Inc. is a payments technology company that provides prepaid card programs, integrated payment processing, and digital banking/payment solutions for businesses, healthcare and pharmaceutical clients, and government or consumer payout programs.
- 🎯 Current $12.83 is 9% below 3yr high $14.14 · ⏳ SMA200 $6.78 (current price $12.83 is above) · 💰 Market Cap $724M
- PAYS shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 450% (>20%); Revenue growth 48% (>15%); ROE 26% (>15%); Low LT D/E 0.06 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (12.6%)
- 📈 RSI at 54 in healthy mid-range
📢 Sentiment (S): 7/10
- 🗞️ News sentiment is positive (mixed coverage; ✅×3 ❌×1 ⚪️×1; showing 4 of 5).
✅ Paysign Targets $117M Revenue as Patient-Affordability Business Surges — MarketBeat.
🤖 Paysign's patient-affordability business is reported to be accelerating, with the company targeting up to $117 million in revenue. The growth outlook is a favorable fundamental catalyst for the stock.
✅ Paysign auf Konferenz: Zweigleisiges Wachstum bei Plasma und Patientenzuzahlungen — Investing.com.
🤖 At the Midwest IDEAS Conference, Paysign described growth in both plasma payments and patient-affordability programs, with patient-affordability revenue up more than 85% year over year in the first half. Management reaffirmed 2026 revenue guidance of $114 million to $117 million and adjusted EBITDA guidance of $35 million to $38 million.
❌ Paysign chief innovation officer Michael Ngo sells $1.9m in stock — Investing.com.
🤖 Paysign's chief innovation officer sold 150,000 shares for approximately $1.92 million in September. The insider sale may be viewed negatively, though the article also notes the company's recent earnings beat and increased full-year outlook.
⚪️ Paysign: Growth In Both Segments, But Guidance Implies Lower H2 Earnings — Seeking Alpha.
🤖 The analysis highlights 48.1% year-over-year Q2 revenue growth, a return to growth in plasma, and twice-raised 2026 guidance. It also flags that the outlook implies lower second-half earnings, creating a mixed near-term setup.
🍭 Bonus (B): 0/10 — Business Services

🏢 What they do: Ooma, Inc. provides cloud-based VoIP phone systems and unified communications services for businesses and consumers, featuring voice, messaging, video, and AI tools like call transcriptions and answering services. Their primary offerings include Ooma Office for small to mid-sized businesses, Ooma AirDial for POTS line replacement, and Ooma Telo for affordable residential landline service.
- 🎯 Current $22.81 is 2% below 3yr high $23.38 · ⏳ SMA200 $16.03 (current price $22.81 is above) · 💰 Market Cap $625M
- OOMA shows decent technicals supported by positive sentiment.

💎 Quality (Q): 54/60
- 🏦 Low drawdown (14.2% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 150% (>20%); Revenue growth 25% (>15%); Low LT D/E 0.46 (<1.0).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ What is Lake Street Capital's Forecast for Ooma Q3 Earnings? — MarketBeat.
🤖 Lake Street Capital raised its Q3 2027 EPS forecast for Ooma from $0.20 to $0.21 while maintaining a Buy rating and a $25 price target, indicating improved analyst expectations.
✅ Citizens Jmp Issues Positive Estimate for Ooma Earnings — MarketBeat.
🤖 Citizens JMP increased its Q3 2027 EPS estimate to $0.21 from $0.20 and maintained a favorable outlook. The report also noted Ooma’s latest quarterly results exceeded consensus estimates.
✅ Ooma Named Top VoIP Provider by IT Professionals in 2026 Spiceworks Voice of IT Survey — Business Wire.
🤖 Ooma was ranked the top standalone VoIP provider by 236 IT professionals in the 2026 Spiceworks survey. The recognition may support Ooma’s brand, competitive position, and customer demand.
🍭 Bonus (B): 10/10 — Computer Processing & Data Prep (Technology sector)

🏢 What they do: Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States, focused on helping employers manage workplace injuries and employee health. Its services include occupational health centers, onsite employer clinics, telemedicine, workers’ compensation care, and other direct-to-employer health services.
- 🎯 At/above 3yr high $35.81 (current $35.81) · ⏳ SMA200 $25.50 (current price $35.81 is above) · 💰 Market Cap $4.6B
- CON shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (8.4% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 46% (>20%); ROE 42% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 3/20
- 📈 RSI at 67 showing strength
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×4 ⚪️×1; showing 3 of 5).
✅ Concentra Group Holdings Parent (NYSE:CON) Reaches New 52-Week High — MarketBeat.
🤖 CON reached a new 52-week high, while the article cited a $43 JPMorgan price target, Weiss Ratings upgrade, and recent Zacks upgrade. These developments indicate strong technical momentum and favorable analyst sentiment.
✅ JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Concentra Group Holdings Parent (NYSE:CON) Stock — MarketBeat.
🤖 JPMorgan raised its price target from $34 to $43 and maintained an overweight rating, implying substantial upside from the cited share price. The article also noted that CON exceeded quarterly earnings and revenue expectations.
⚪️ Concentra Appoints Tanner Newton Chief Financial Officer — Business Wire.
🤖 Concentra appointed Tanner Newton, its senior vice president of strategy and finance, as executive vice president and CFO effective November 1, 2026. The planned internal promotion provides continuity but has no clearly stated immediate financial impact.
🍭 Bonus (B): 0/10 — Specialty Outpatient Facilities

🏢 What they do: ScanSource is a technology distributor that connects hardware, software, connectivity, and cloud solutions to channel partners and businesses. Its products and services include point-of-sale systems, barcode and data-capture equipment, networking, communications, physical security, payments, and related value-added services.
- 🎯 Current $58.59 is 0% below 3yr high $58.89 · ⏳ SMA200 $44.51 (current price $58.59 is above) · 💰 Market Cap $1.2B
- SCSC shows decent technicals supported by positive sentiment.

💎 Quality (Q): 55/60
- 🏦 Low drawdown (12.7% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 40% (>20%); Revenue growth 17% (>15%); Low LT D/E 0.38 (<1.0).
⏰ Entry (E): 2/20
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ ScanSource Completes Acquisition of MicroAge — Yahoo Finance.
🤖 ScanSource completed its acquisition of MicroAge, expanding its technology distribution and services capabilities. The closing delivers on the previously announced strategic transaction and supports broader reach in end-user IT markets.
✅ ScanSource (SCSC) Just Posted Record Earnings And A ... — Yahoo Finance.
🤖 The article highlights ScanSource's record non-GAAP profit, 17.3% year-over-year sales growth, and 43.1% increase in non-GAAP EPS in its August 20 results. It also notes the $220.5 million MicroAge acquisition agreement, reinforcing the company’s growth strategy.
✅ SCSC Q2 Deep Dive: Large Deal Timing and Unified Sales ... — Yahoo Finance.
🤖 ScanSource reported revenue of $953.1 million, above analyst expectations, and non-GAAP EPS of $1.46, 28% above consensus. The earnings outperformance and post-results share appreciation are positive catalysts.
🍭 Bonus (B): 0/10 — Computers & Software - Wholesale

🏢 What they do: Avnet, Inc. is a global distributor of electronic components and a technology solutions provider that supports engineers, entrepreneurs, and startups in taking tech projects from idea and design to prototype and mass production.
- 🎯 Current $92.34 is 7% below 3yr high $99.63 · ⏳ SMA200 $72.33 (current price $92.34 is above) · 💰 Market Cap $7.6B
- AVT shows decent technicals supported by positive sentiment.

💎 Quality (Q): 54/60
- 🏦 Low drawdown (12.5% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 1578% (>20%); Revenue growth 48% (>15%); Low LT D/E 0.39 (<1.0).
⏰ Entry (E): 2/20
- 📈 RSI at 51 in healthy mid-range
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×4 ⚪️×1; showing 3 of 5).
✅ Avnet, Inc. (NASDAQ:AVT) Given Consensus Rating of "Moderate Buy" by Brokerages — MarketBeat.
🤖 Brokerages covering Avnet had an average "Moderate Buy" rating. The article also noted the company’s prior earnings beat and dividend increase, though the core new item is the favorable analyst consensus.
✅ Avnet (AVT) Lifts Dividend After Buybacks And Growth While Fair ... — Yahoo Finance.
🤖 Avnet’s board approved a 5.7% increase in its quarterly cash dividend to $0.37 per share. A dividend increase is a shareholder-return positive and signals management confidence in capital allocation.
⚪️ Why Is Avnet (AVT) Down 6.2% Since Last Earnings Report? — Yahoo Finance.
🤖 The article noted AVT had fallen 6.2% since its earnings release despite reporting fiscal fourth-quarter adjusted EPS of $2.28, above the $1.76 Zacks consensus estimate. The mixed post-earnings share performance and earnings beat support a neutral assessment.
🍭 Bonus (B): 0/10 — Electronic Parts - Wholesale

🏢 What they do: CareDx, Inc. is a precision medicine company focused on transplant patients. It develops diagnostics, digital health tools, lab products, and patient support services to help monitor care before and after organ transplantation.
- 🎯 At/above 3yr high $52.37 (current $52.37) · ⏳ SMA200 $25.86 (current price $52.37 is above) · 💰 Market Cap $2.7B
- CDNA shows decent technicals supported by positive sentiment.

💎 Quality (Q): 59/60
- 🏦 Low drawdown (12.3% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 1394% (>20%); Revenue growth 52% (>15%); ROE 26% (>15%).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (7.2%)
- 🔔 Strong above EMA50 (20.9%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 68 showing strength
📢 Sentiment (S): 6/10
- 🗞️ News sentiment is positive (✅×1 ⚪️×4; showing 3 of 5).
✅ Bamco Inc. NY Makes New $55.21 Million Investment in CareDx, Inc. — MarketBeat.
🤖 The article reports CareDx revenue growth of 52.2% year over year and adjusted EPS of $0.37, above the $0.23 consensus estimate. It also cites bullish analyst actions, including higher price targets and an upgrade to Buy, providing a positive catalyst despite the accompanying institutional filing.
⚪️ Squarepoint Ops LLC Raises Stock Holdings in CareDx, Inc. — MarketBeat.
🤖 Squarepoint increased its CareDx holdings by 759.5% during the second quarter, according to a Form 13F filing. This is a routine, backward-looking institutional ownership disclosure and is therefore classified as neutral.
⚪️ Hsbc Holdings PLC Boosts Stake in CareDx, Inc. $CDNA — MarketBeat.
🤖 HSBC increased its CareDx stake by 411.2% during the second quarter. The article also repeats previously reported earnings and analyst information, but the institutional transaction itself is a routine ownership disclosure, so the item is classified as neutral.
🍭 Bonus (B): 0/10 — Medical Laboratories